The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Prof. Mark Levis | ASH 2017 | Overview of FLT3 inhibitors in AML

Dec 8, 2017

59th ASH Annual Meeting and Exposition, 9–12 Dec 2017, Atlananta, GA

Profssor Mark Levis

 

Overview of FLT3 inhibitors in AML